# Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

> **NCT04649255** · NA · COMPLETED · sponsor: **BlackSwan Vascular, Inc.** · enrollment: 113 (actual)

## Conditions studied

- Peripheral Arterial Hemorrhage

## Interventions

- **DEVICE:** Liquid Embolic

## Key facts

- **NCT ID:** NCT04649255
- **Lead sponsor:** BlackSwan Vascular, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-14
- **Primary completion:** 2022-08-17
- **Final completion:** 2022-08-17
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2024-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04649255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04649255, "Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04649255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*